Departamento de Oftalmologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
Arq Bras Oftalmol. 2021 Jan-Feb;84(1):45-50. doi: 10.5935/0004-2749.20210008.
To determine whether codeine plus acetaminophen after photorefractive keratectomy (PRK) have beneficial effects on sleep quality, activity levels, and food intake, beyond their effect of pain relief.
We enrolled 40 patients (80 eyes) in this randomized, double-blind, paired-eye, placebo-controlled, add-on trial. Each eye was treated 2 weeks apart, and the patients were randomly allocated to receive either the placebo or the intervention (30 mg codeine and 500 mg acetaminophen) (4 times a day for 4 days). Outcomes were sleep quality, daily activity level, and food intake within 24-72 h post-photorefractive keratectomy, as measured by the McGill Pain Questionnaire.
Sleep quality and daily activity level were inversely associated with pain scores within the first 48 h post-photorefractive keratectomy. During the intervention, patients were significantly more likely to score their sleep quality as good at 24 h (relative risk=2.5; 95% confidence interval 1.48-4.21, p<0.001) and 48 h compared to during placebo (relative risk=1.37; 95% confidence interval: 1.03-1.84, p=0.023). The probability of reporting good daily activity level at 24 and 72 hours post-photorefractive keratectomy was three times higher when patients received the intervention compared to the placebo (relative risk=3.0; 95% confidence interval: 1.49-6.15, p=0.006 and relative risk=1.31; 95% confidence interval: 1.02-1.67, p=0.021, respectively). No difference was observed in food intake.
The oral combination of codeine and acetaminophen significantly improves sleep quality and daily activity level within the first 24-72 h post-photorefractive keratectomy compared to a placebo.
确定氨酚可待因(每片含 30 毫克可待因和 500 毫克对乙酰氨基酚)在光折射性角膜切除术(PRK)后是否除了缓解疼痛外,对睡眠质量、活动水平和食物摄入还有有益影响。
我们进行了这项随机、双盲、配对眼、安慰剂对照、附加试验,共纳入 40 例(80 只眼)患者。每只眼相隔 2 周接受治疗,患者被随机分配接受安慰剂或干预(4 次/天,共 4 天)。结局是在 PRK 后 24-72 小时内通过麦吉尔疼痛问卷测量的睡眠质量、每日活动水平和食物摄入。
在 PRK 后前 48 小时内,睡眠质量和日常活动水平与疼痛评分呈负相关。在干预期间,与安慰剂相比,患者在 24 小时(相对风险=2.5;95%置信区间 1.48-4.21,p<0.001)和 48 小时时更有可能将睡眠质量评为良好,48 小时时(相对风险=1.37;95%置信区间:1.03-1.84,p=0.023)。与安慰剂相比,患者接受干预时在 PRK 后 24 和 72 小时报告良好日常活动水平的概率高三倍(相对风险=3.0;95%置信区间:1.49-6.15,p=0.006 和相对风险=1.31;95%置信区间:1.02-1.67,p=0.021)。食物摄入没有差异。
与安慰剂相比,氨酚可待因口服联合治疗在 PRK 后 24-72 小时内显著改善睡眠质量和日常活动水平。